GARP (GARP)

This article details Embree Financial Group's holding history in the iShares MSCI USA Quality GARP ETF (GARP). As of June 30, 2026, Embree Financial Group holds 158,151 shares valued at $13.06 million, representing 1.31% of their portfolio. The firm has an estimated gain of $1.10 million on this investment, reflecting a 9.21% return since their initial trade in Q2 2026.

The Global X S&P World Ex Australia GARP ETF (ASX:GARP) provides exposure to 251 large global companies outside Australia, selected using a growth-at-a-reasonable-price methodology. With a fund size of $127.99 million, its portfolio is heavily weighted towards Financial Services (23.59%) and Technology (22.38%), with 66.18% of geographic exposure in the United States. The ETF's top 10 holdings, including Eli Lilly and Alphabet, account for 38.18% of the fund.

This page provides financial information for the iShares MSCI USA Quality GARP ETF (BGAR39) on the B3 exchange. It details the company's financial overview, statements, statistics, dividends, earnings, and segment performance. The content is primarily a data navigation and display interface rather than a textual article.

The iShares MSCI USA Quality GARP ETF (QGAP) has declared a quarterly distribution of $0.0528 per share. This declaration comes as the ETF continues to manage its portfolio focused on growth at a reasonable price (GARP) and quality factors within the US market. Additional details regarding the ex-dividend date and payment date were not provided in this snippet.

The iShares MSCI USA Quality GARP ETF (QGAP) has announced a quarterly distribution of $0.0528 per share. This distribution will be payable to shareholders of record as of the specified date.